Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041886 | SCV000065582 | benign | not specified | 2011-11-03 | criteria provided, single submitter | clinical testing | Cys2123Cys in exon 33 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located near a splice junction and has been identified in 1.7% (77/4550) of control chromosom es (dbSNP rs111033472). |
ARUP Laboratories, |
RCV000755430 | SCV000605551 | benign | not provided | 2023-11-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000755430 | SCV001036374 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000755430 | SCV001146616 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755430 | SCV001894571 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450875 | SCV004181671 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450874 | SCV004181672 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000755430 | SCV005280580 | benign | not provided | criteria provided, single submitter | not provided |